Inhibition of Geranyl-Geranyl Prenylation by Statins: A Novel Model of Disease Modification of Systemic Sclerosis

E-ISSN： 1875-628x|3|3|183-187

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.3, 2006-04, pp. : 183-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A new geranyl flavanone from Macaranga triloba

By Dinh Vinh

Journal of Asian Natural Products Research, Vol. 8, Iss. 1-2, 2006-01 ,pp. : 155-158

Taylor & Francis Ltd

Access to resources Recommend Favorite

Targeting Vascular Disease in Systemic Sclerosis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 401-407

Bentham Science Publishers

Access to resources Recommend Favorite

Review: Evidence That Systemic Sclerosis Is a Vascular Disease

Arthritis & Rheumatism, Vol. 65, Iss. 8, 2013-08 ,pp. : 1953-1962

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discrepant Effects of Human Interferon-gamma on Clinical and Immunological Disease Parameters in a Novel Marmoset Model for Multiple Sclerosis

By Jagessar S.

Journal of Neuroimmune Pharmacology, Vol. 7, Iss. 1, 2012-03 ,pp. : 253-265

Springer Publishing Company

Access to resources Recommend Favorite

Interstitial Lung Disease in Systemic Sclerosis: Pathophysiology, Current and New Advances in Therapy

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 11, Iss. 4, 2012-08 ,pp. : 266-277

Bentham Science Publishers

Access to resources Recommend Favorite